Viqugim-M 1mg/500mg Tablet SR

Overview Viqugim-M 1mg/500mg Tablet SR

Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with well-managed blood sugar; premature discontinuation, without medical consultation, risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. The most frequent adverse reaction to Diabexe Duo is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms – sweating, dizziness, headache, tremors – and appropriate countermeasures. Consistent mealtimes and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are vital preventative steps. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function as directed by your physician.

Uses of Viqugim-M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Viqugim-M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Viqugim-M 1mg/500mg extended-release tablet should be taken with a meal.

Common Side effects of Viqugim-M 1mg/500mg Tablet SR:

• Headache
• Hypoglycemia (low blood glucose level)
• Nausea
• Diarrhea

How to use Viqugim-M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Viqugim-M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Viqugim-M 1mg/500mg Tablet SR works:

Viqugim-M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose uptake, and enhancing insulin responsiveness.

What if you forget to take Viqugim-M 1mg/500mg Tablet SR :

Should you forget a Viqugim-M 1mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.